KenarJhaveri United States

Back

Upload Picture

First Name

Kenar

Last Name

Jhaveri

Institution

Country.

United States

Friday, February 7, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course GeorgiAbraham Chair abraham_georgi@yahoo.comMGM Healthcare, Chennai, IndiaIndia KriangTungsanga Chair kriangtungsanga@hotmail.comDepartment of Medicine, Faculty of Medicine, Chulalongkorn UnviersityThailand Renal Complications of Novel Cancer Therapies: Practical Insights AnushreeShirali Speaker Immune Checkpoint Inhibitors and AKI MitchellRosner Speaker Univeristy of Virginia HealthUnited States Electrolyte Abnormalities in the Cancer Patient JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland Opening an Onconephrology Clinic - What Should You Be Aware of? KenarJhaveri Speaker United States Q&A Amaltas A Hall B101A

Time

Session

9:45 a.m.

11:15 a.m.

Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course

GeorgiAbraham Chair abraham_georgi@yahoo.comMGM Healthcare, Chennai, IndiaIndia

KriangTungsanga Chair kriangtungsanga@hotmail.comDepartment of Medicine, Faculty of Medicine, Chulalongkorn UnviersityThailand

Renal Complications of Novel Cancer Therapies: Practical Insights

AnushreeShirali Speaker
Immune Checkpoint Inhibitors and AKI

MitchellRosner Speaker Univeristy of Virginia HealthUnited States
Electrolyte Abnormalities in the Cancer Patient

JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
Opening an Onconephrology Clinic - What Should You Be Aware of?

KenarJhaveri Speaker United States
Q&A

Amaltas A Hall B101A

Thursday, February 6, 2025

Time	Session

9 a.m. 11 a.m.	Annual Review of Nephrology Course: Managing Kidney Failure KenarJhaveri Chair United States ManishaSahay Chair India MitchellRosner Chair Univeristy of Virginia HealthUnited States New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals KrishnaswamySampathkumar Speaker Meenakshi Mission Hospital India Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue? Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore Q and A Neelkamal Hall 305
11:30 a.m. 1:30 p.m.	Annual Review of Nephrology Course: Best Practices in Diabetic Kidney Disease Care KenarJhaveri Chair United States ManishaSahay Chair India MitchellRosner Chair Univeristy of Virginia HealthUnited States Clinical Trials Overview: Focus on GLP1a, MRA, and SGLT2 MaartenTaal Speaker University of NottinghamUnited Kingdom SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach MadhukarMisra Speaker misram@health.missouri.eduUniversity of Missouri Columbia, USAUnited States Q and A Neelkamal Hall 305
2:15 p.m. 4:15 p.m.	Annual Review of Nephrology Course: Electrolyte Management in the ICU KenarJhaveri Chair United States ManishaSahay Chair India MitchellRosner Chair Univeristy of Virginia HealthUnited States Approaches to the Patient with Severe Hyponatremia and Acute Kidney Injury MitchellRosner Speaker Univeristy of Virginia HealthUnited States Approaches to Severe Hypercalcemia KenarJhaveri Speaker United States Approaches to Severe Hyperkalemia KSNayak Speaker Virinchi HospitalsIndia Q and A Neelkamal Hall 305